!DOCTYPE html> Your Page Title

Royalty Pharma is a leading biopharmaceutical investment company, headquartered in New York City. They specialize in acquiring and managing royalty interests in cutting-edge, revenue-generating pharmaceutical and biotechnology products. With a proven track record in healthcare investments, Royalty Pharma plays a pivotal role in supporting innovations and treatments that improve global health.

Royalty Pharma Dividend Announcement

• Royalty Pharma announced a Quarterly dividend of $0.21 per ordinary share which will be made payable on 2024-06-14. Ex dividend date: 2024-05-16
• Royalty Pharma annual dividend for 2023 was $0.80
• Royalty Pharma dividend growth for 2022 - 2023 was 5.26%
• Typically, Royalty Pharma pays dividends four times

Royalty Pharma Dividend History

Ex-Div date Dividend amount Dividend type Pay date
16-05-2024 $ 0.21 Quarterly 14-06-2024
15-02-2024 $ 0.21 Quarterly 15-03-2024
16-11-2023 $ 0.20 Quarterly 15-12-2023
17-08-2023 $ 0.20 Quarterly 15-09-2023
18-05-2023 $ 0.20 Quarterly 15-06-2023
15-02-2023 $ 0.20 Quarterly 15-03-2023
17-11-2022 $ 0.19 Quarterly 15-12-2022
18-08-2022 $ 0.19 Quarterly 15-09-2022
19-05-2022 $ 0.19 Quarterly 15-06-2022
17-02-2022 $ 0.19 Quarterly 15-03-2022
18-11-2021 $ 0.17 Quarterly 15-12-2021
19-08-2021 $ 0.17 Quarterly 15-09-2021
19-05-2021 $ 0.17 Quarterly 15-06-2021
18-02-2021 $ 0.17 Quarterly 15-03-2021
19-11-2020 $ 0.15 Quarterly 15-12-2020
14-09-2020 $ 0.15 Quarterly 30-09-2020

Royalty Pharma Dividend per year

Dividend $ per ordinary share

Royalty Pharma Dividend growth

Royalty Pharma Dividend Yield

Are you planning on buying Royalty Pharma? Calculate your expected dividend yield:

Dividend Amount:
Dividend Frequency:
Share Price:
Dividend Yield

Royalty Pharma HOLDING NV ADR (Royalty Pharma)

Royalty Pharma Holding NV ADR Financial Data Overview

  • Prev. Close 28.07
  • Volume 3080807
  • Low
  • Market Cap M
  • Shares Outstanding M
  • EPS
  • Beta
  • Open 27.71
  • High
  • 52 wk Range -
  • P/E Ratio
  • Revenue M
  • Dividends (Yield)

Royalty Pharma Dividend policy

Royalty Pharma, a leading biopharmaceutical investment company, has a prudent dividend policy that aligns with its unique business model. As a company that acquires royalty interests in pharmaceutical products, Royalty Pharma’s dividends are primarily generated from its royalty streams. The company typically pays out a substantial portion of its cash flow to shareholders in the form of dividends. However, the dividend amounts can vary depending on the performance of the underlying pharmaceutical products in its portfolio. Royalty Pharma aims to provide a steady and attractive income to its investors while maintaining financial flexibility to seize new investment opportunities and manage risks. This policy allows shareholders to benefit from the success of breakthrough drugs in the market.

Royalty Pharma Dividend FAQ


Royalty Pharma’s board of directors will review the company’s financial performance, cash flow, future investment needs, and other relevant factors to determine the next Royalty Pharma dividend. The next Royalty Pharma dividend will be released in March, June, September or December.

Royalty Pharma pays dividends on a Quarterly basis. The specific dates may vary each year but are generally around March, June, September and December. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.

The specific amount of Royalty Pharma dividend can vary from quarter to quarter and year to year, based on a variety of factors including the company’s financial performance, the global economic situation, and the decisions of its board of directors. In the above tabel you can find Royalty Pharma’s dividend history.

Yes, Royalty Pharma does pay dividends to its shareholders. However, the specific amount and frequency of these dividends can vary based on a variety of factors, including the company’s financial performance, the global economic situation, and the decisions of its board of directors. In the above tabel you can find Royalty Pharma’s dividend history.

To find the most up-to-date information on Royalty Pharma’s dividend payments in 2023, please look at the top of this page, specifically in the table labeled ‘Royalty Pharma Dividend.’ Royalty Pharma paid$1.52 in 2022, $1.36 in 2021 and $0.60 in 2020.

Royalty Pharma typically pays dividends on a Quarterly basis. This means that dividends are usually distributed four times a year. The specific payout dates may vary each year but generally fall around March, June, September and December.

The dividend yield is calculated by dividing the annual dividend payment by the price of the stock. Both of these numbers can fluctuate daily due to changes in the stock price and any updates to the dividend payment. Use the dividend calculator on this page to calculate Royalty Pharma’s exact dividend yield.

Royalty Pharma typically goes ex-dividend a few weeks before the payment date each quarter. The specific dates can vary each year and for each dividend payment.

Royalty Pharma pays dividends on a Quarterly basis, typically around March, June, September and December, but the exact dates can vary each year.

Decisions about dividend payments are made by the company’s board of directors and are based on a variety of factors, including the company’s earnings, financial health, future business prospects, and the overall economic environment. I

To find the most up-to-date information on Royalty Pharma’s dividend payments in 2023, please look at the top of this page, specifically in the table labeled ‘Royalty Pharma Dividend.’Royalty Pharma paid$1.52 per share in 2022, $1.36 per share in 2021 and $0.60 per share in 2020. The amount of dividend per share that Royalty Pharma pays can vary each quarter based on a range of factors including the company’s earnings, financial health, and decisions made by its board of directors.

Royalty Pharma is not considered a Dividend Aristocrat. The term “Dividend Aristocrat” is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.

Royalty Pharma is not classified as a “Dividend King”. A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.

Yes, Royalty Pharma is considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.

Whether Royalty Pharma is a good dividend stock depends on several factors and can vary depending on individual investment goals, risk tolerance, and the overall market conditions. Royalty Pharma has a history of paying regular dividends, which can make it attractive to income-focused investors.

Other factors to consider when evaluating Royalty Pharma as a dividend stock include its dividend yield, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company’s ability to maintain or increase its dividend in the future.


Royalty Pharma paid$1.52 in 2022, $1.36 in 2021 and $0.60 in 2020. To find the most up-to-date information on Royalty Pharma’s dividend payments in 2023, please look at the top of this page, specifically in the table labeled ‘Royalty Pharma Dividend.

Like many large, publicly traded companies, Royalty Pharma typically pays dividends on a Quarterly basis.

Royalty Pharma currently pays dividends on a Quarterly basis.

Royalty Pharma currently pays dividends on a Quarterly basis.

Yes, Royalty Pharma does pay dividends to its shareholders. Royalty Pharma has been known for its dividend payments and has had a track record of distributing dividends to its shareholders.

Yes, Royalty Pharma has a history of paying dividends to its shareholders. Royalty Pharma is known for its dividend payments, which have made it an attractive investment for income-focused investors.

To buy Royalty Pharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees, account minimums, and the availability of dividend reinvestment programs (DRIPs) if you wish to reinvest your dividends automatically.

Place an order: Use the brokerage’s trading platform to place an order to buy Royalty Pharma stock.

Remember that buying stocks involves risk, and it’s important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.


Royalty Pharma pays dividends on a Quarterly basis. 2023 dividend payments are in March, June, September and December. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.

Decisions regarding Royalty Pharma dividend increases are typically made by a company’s board of directors based on various factors, including financial performance, cash flow, investment needs, and market conditions. For an up-to-date Royalty Pharma dividend overview you can look into the above table.

The Royalty Pharma dividend works by distributing a portion of the company’s profits to its shareholders on a per-share basis. Here’s a general overview of how Royalty Pharma’s dividend process works:

1. Determination of Dividend: Royalty Pharma’s board of directors reviews the company’s financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Royalty Pharma publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Royalty Pharma distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder’s brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Royalty Pharma are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction’s tax regulations.


Royalty Pharma dividends are typically paid in cash directly to eligible shareholders. The payment process involves the following steps:

1. Record Date: Royalty Pharma sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Royalty Pharma distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder’s brokerage account or bank account.
3. Currency: Company-Name declares the currency in which the dividend will be paid. Depending on the shareholder’s location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.


Royalty Pharma typically pays dividends on a Quarterly basis. The specific payment dates can vary each year and are usually announced when the company releases its financial results for each quarter.

Royalty Pharma traditionally pays dividends on a Quarterly basis, and the specific months can vary from year to year. The general pattern is that Royalty Pharma pays dividends around March, June, September and December. However, the exact payment dates can vary each year and are typically announced when the company releases its financial results for each quarter.

Royalty Pharma has a history of paying dividends to its shareholders. To find the most up-to-date information on Royalty Pharma’s dividend payments, please look at the top of this page, specifically in the table labeled ‘Royalty Pharma Dividend.

The safety of Royalty Pharma’s dividend is subject to various factors and cannot be determined with certainty. It is influenced by the company’s financial performance, cash flow, and the overall economic and industry conditions.

To assess the safety of Royalty Pharma’s dividend, it is crucial to analyze the company’s financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company’s future earnings, cash flow projections, and management’s commitment to dividend policies can provide valuable insights.

It is recommended to review Royalty Pharma’s financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company’s financial situation.

Similar stocks

Dividend news